These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14790321)

  • 1. Experimental and therapeutic investigations with certain new hydrogenated ergot alkaloids in peripheral vascular disorders.
    KAPPERT A; HADRON W
    Angiology; 1950 Dec; 1(6):520-9. PubMed ID: 14790321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydrogenated ergot alkaloids (hydergin) in therapy of peripheral circulatory disorders].
    EHREN H
    Dtsch Med Wochenschr; 1951 Oct; 76(43):1334-7. PubMed ID: 14896779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of peripheral vascular diseases with hydrogenated ergot alkaloids].
    ZOZAYA RG
    Praxis; 1956 Jun; 45(25):575-8. PubMed ID: 13349989
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of some dihydrogenated alkaloids of ergot in the management of chronic peripheral vascular diseases.
    POPKIN RJ
    Angiology; 1951 Apr; 2(2):114-24. PubMed ID: 14819708
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical effectiveness of certain of the hydrogenated alkaloids of ergot in peripheral vascular disorders.
    ROBERTS JE; ANDERSON LL; PARRY TM
    Am J Med Sci; 1952 Oct; 224(4):431-8. PubMed ID: 12976388
    [No Abstract]   [Full Text] [Related]  

  • 6. [Certain hydrogenated ergot alkaloids in the therapy of hypertensive disease].
    DONZELOT E; KAUFMANN H; COZANET P; JEGOU L
    Sem Hop; 1952 Apr; 28(25):1058-62. PubMed ID: 14958421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of peripheral vascular diseases with hydrogenated alkaloids of ergot (hydergine)].
    GARCIA ZOZAYA R
    Rev Clin Esp; 1955 May; 57(4):235-41. PubMed ID: 13255203
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of hydrogenated ergot alkaloids on elevated blood pressure levels.
    LABECKI TD; BRIGHT IB; GABLE GP; HAMILTON HN
    Miss Doct; 1953 Aug; 31(3):80-4. PubMed ID: 13072180
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrogenated ergot alkaloids in treatment of intermittent claudication.
    LUKE JC; MARIEN BN
    Can Med Assoc J; 1953 Mar; 68(3):221-4. PubMed ID: 13032858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of peripheral circulatory disorders with hydrogenated alkaloids of ergot of rye].
    ZOZAYA RG
    Presse Med (1893); 1956 Jun; 64(47):1086-7. PubMed ID: 13350074
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of trophic ulcers of the soles of the feet in leprosy with certain hydrogenated ergot alkaloids.
    GOKHALE BB
    Dermatologica; 1956 Sep; 113(3):142-55. PubMed ID: 13375149
    [No Abstract]   [Full Text] [Related]  

  • 12. The hydrogenated ergot alkaloids (hydergine); a hypotensive agent.
    SCHULTZ FB
    Am Pract Dig Treat; 1953 May; 4(5):330-6. PubMed ID: 13050917
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative analysis of the effect of hydrogenated ergot alkaloids upon the presso- and chemoreceptive reflexes in the cat.
    SUTTON GC; CERLETTI A; ROTHLIN E
    J Lab Clin Med; 1950 Dec; 36(6):994-5. PubMed ID: 14795088
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative analysis of the effect of hydrogenated ergot alkaloids upon presso- and chemoreceptive reflexes in the cat.
    SUTTON GC; CERLETTI A; TAESCHLER M
    Arch Int Pharmacodyn Ther; 1950 Dec; 84(2-3):393-400. PubMed ID: 14790883
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydrogenated ergot alkaloids (hydergine) in the treatment of geriatric postural dizziness.
    ORMA EJ
    Ann Med Intern Fenn; 1956; 45(1):39-44. PubMed ID: 13355071
    [No Abstract]   [Full Text] [Related]  

  • 16. [INTRA-ARTERIAL PRISCOL AND HYDERGIN IN PERIPHERAL VASCULAR DISEASE)].
    WEISER HI
    Harefuah; 1964 Jun; 66():407-10. PubMed ID: 14173940
    [No Abstract]   [Full Text] [Related]  

  • 17. [DRUG THERAPY OF OBLITERATIVE PROCESSES OF PERIPHERAL ARTERIOPATHIES].
    STRANO A
    Med Welt; 1965 Mar; 12():603-9. PubMed ID: 14293113
    [No Abstract]   [Full Text] [Related]  

  • 18. [RESULTS OBTAINED WITH HYPACOM IN THE TREATMENT OF PERIPHERAL ANGIOPATHIES].
    GARCIAZOZAYA R
    Cir Ginecol Urol; 1965; 19():27-38. PubMed ID: 14290989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrocardiographic and kymographic investigations in erect posture before- and after hydrogenized ergot alkaloids in relation to leucocyte- and blood sugar behavior].
    STRODER U
    Cardiologia (Basel); 1950; 17(3-4):127-73. PubMed ID: 14801791
    [No Abstract]   [Full Text] [Related]  

  • 20. [DETERMINATION OF NON-HYDROGENATED AND HYDROGENATED ERGOT ALKALOIDS].
    GAWRYCH Z; WILCZYNSKA I
    Acta Pol Pharm; 1965; 22():1-12. PubMed ID: 14311546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.